SunHo BioTech Group Ltd (SGSH)

SunHo BioTech Group will go public soon, but the exact IPO date is still unknown.

IPO Price

$4.00

Shares Offered

2,500,000

Deal Size

$10.00M

SunHo BioTech Group Income Statement

Financials in millions SGD. Fiscal year is January - December.

Millions SGD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	5.6	3.07	0.56
Revenue Growth (YoY)	-	443.58%	-
Cost of Revenue	-	1.1	0.25
Gross Profit	4.25	1.97	0.32
Selling, General & Admin	-	5.25	4.82
Other Operating Expenses	0	0.63	0.64
Operating Expenses	-	5.88	5.47
Operating Income	-1.88	-3.91	-5.15
Interest Expense / Income	-	0.63	0.64
Other Expense / Income	-0.54	-1.55	-0.96
Pretax Income	-1.34	-2.98	-4.83
Income Tax	-	-0.21	0.13
Net Income	-1.34	-2.77	-4.96
Free Cash Flow	-2.97	-3.97	-2.24
Gross Margin	75.89%	64.31%	56.36%
Operating Margin	-33.50%	-127.23%	-911.95%
Profit Margin	-23.86%	-90.28%	-878.19%
Free Cash Flow Margin	-53.10%	-129.27%	-396.49%
EBITDA	-	-0.18	-2.07
EBITDA Margin	-	-5.77%	-366.16%
Depreciation & Amortization	-	2.18	2.12
EBIT	-	-2.36	-4.18
EBIT Margin	-	-76.78%	-741.09%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).